Citation Data Identify Apoptosis, Thrombosis As Hot Research Areas

Patients recovering from an operation will often find themselves given elasticated stockings to wear and injections of subcutaneous heparin to undergo. These are ways of trying to prevent clots forming in the deep veins of the legs. Pulmonary thromboembolism caused by the migration of such clots remains a potentially fatal complication of surgery. Cancer can put patients at risk of venous thrombosis, but all too often, even when there is a family history of this condition, laboratory tests thro

Written byJeremy Cherfas
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The delicate, complex balance between coagulation and anticoagulation attracts both admiration and some wonderment that things do not go wrong more often. The protein C anticoagulant pathway is part of the story.

Papers No. 3 and No. 5 show how a substantial proportion of venous thrombosis that is not otherwise explained is caused by resistance to activated protein C (APC). How big a fraction depends on the selection criteria for the study up to a fifth, maybe, but more when there is a familial history.

In February 1994, Peter J. Svensson and Bjorn Dahlbäck (paper No. 3) suggested that APC was caused by a single gene, but they did not say where that defect might lie. In fact, a recent paper from their group had just revealed that defective factor V was involved. A slightly earlier paper, No. 5, from the Leiden Thrombophilia Study, also referred to "as yet unknown ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies